| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroendocrine Tumors | 39 | 2024 | 594 | 7.720 |
Why?
|
| Medulloblastoma | 19 | 2022 | 683 | 1.890 |
Why?
|
| Pancreatic Neoplasms | 18 | 2023 | 5264 | 1.480 |
Why?
|
| Neuroectodermal Tumors, Primitive | 7 | 2023 | 140 | 1.370 |
Why?
|
| Cerebellar Neoplasms | 10 | 2022 | 587 | 1.320 |
Why?
|
| Brain Neoplasms | 34 | 2023 | 8856 | 1.210 |
Why?
|
| Hedgehog Proteins | 12 | 2022 | 784 | 1.100 |
Why?
|
| Oligodendroglioma | 5 | 2019 | 279 | 0.970 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 21 | 2023 | 11524 | 0.860 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2023 | 332 | 0.840 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2014 | 2110 | 0.830 |
Why?
|
| Intestinal Neoplasms | 6 | 2023 | 319 | 0.790 |
Why?
|
| Dacarbazine | 3 | 2013 | 566 | 0.790 |
Why?
|
| Paraganglioma | 1 | 2022 | 143 | 0.750 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 5 | 2019 | 501 | 0.730 |
Why?
|
| Octreotide | 6 | 2024 | 146 | 0.720 |
Why?
|
| Pheochromocytoma | 1 | 2022 | 337 | 0.710 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2013 | 367 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2019 | 318 | 0.630 |
Why?
|
| Neural Stem Cells | 4 | 2021 | 851 | 0.610 |
Why?
|
| Glioma | 14 | 2023 | 3401 | 0.600 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2022 | 740 | 0.570 |
Why?
|
| Stomach Neoplasms | 5 | 2023 | 1332 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2023 | 8430 | 0.480 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 13691 | 0.480 |
Why?
|
| Repressor Proteins | 5 | 2022 | 3024 | 0.460 |
Why?
|
| Xenograft Model Antitumor Assays | 13 | 2020 | 3547 | 0.450 |
Why?
|
| Colorectal Neoplasms | 14 | 2019 | 6773 | 0.450 |
Why?
|
| Practice Guidelines as Topic | 5 | 2023 | 7270 | 0.450 |
Why?
|
| MicroRNAs | 8 | 2019 | 3750 | 0.430 |
Why?
|
| Supratentorial Neoplasms | 1 | 2013 | 160 | 0.420 |
Why?
|
| Glioblastoma | 12 | 2023 | 3480 | 0.420 |
Why?
|
| Carcinoid Tumor | 5 | 2020 | 235 | 0.400 |
Why?
|
| Rhabdoid Tumor | 3 | 2020 | 212 | 0.400 |
Why?
|
| Neoplastic Stem Cells | 6 | 2023 | 1376 | 0.390 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2015 | 871 | 0.390 |
Why?
|
| Molecular Targeted Therapy | 5 | 2016 | 2727 | 0.380 |
Why?
|
| Teratoma | 3 | 2020 | 393 | 0.380 |
Why?
|
| Sirolimus | 7 | 2013 | 1565 | 0.380 |
Why?
|
| Disease-Free Survival | 17 | 2022 | 6895 | 0.370 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 1585 | 0.360 |
Why?
|
| Consensus | 5 | 2023 | 2954 | 0.360 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2022 | 3510 | 0.350 |
Why?
|
| Humans | 149 | 2024 | 743811 | 0.340 |
Why?
|
| Gene Amplification | 1 | 2013 | 1063 | 0.340 |
Why?
|
| Ependymoma | 3 | 2018 | 334 | 0.340 |
Why?
|
| RNA-Binding Proteins | 3 | 2017 | 1900 | 0.330 |
Why?
|
| Astrocytoma | 3 | 2013 | 790 | 0.330 |
Why?
|
| Guanine | 1 | 2010 | 274 | 0.330 |
Why?
|
| Glutamates | 1 | 2010 | 397 | 0.320 |
Why?
|
| Molecular Imaging | 1 | 2015 | 821 | 0.320 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 3583 | 0.310 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2019 | 3622 | 0.310 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2015 | 1114 | 0.310 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2022 | 9239 | 0.300 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2020 | 6539 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 8 | 2019 | 4463 | 0.290 |
Why?
|
| Infratentorial Neoplasms | 2 | 2018 | 94 | 0.280 |
Why?
|
| Proteoglycans | 2 | 2009 | 837 | 0.280 |
Why?
|
| Nuclear Medicine | 2 | 2020 | 233 | 0.270 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2010 | 640 | 0.270 |
Why?
|
| Mutation | 20 | 2022 | 29777 | 0.270 |
Why?
|
| Female | 82 | 2023 | 380020 | 0.270 |
Why?
|
| Signal Transduction | 18 | 2021 | 23398 | 0.260 |
Why?
|
| Egg Proteins | 4 | 1996 | 58 | 0.260 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2022 | 1581 | 0.260 |
Why?
|
| Cell Proliferation | 16 | 2020 | 10477 | 0.260 |
Why?
|
| Organometallic Compounds | 2 | 2020 | 665 | 0.260 |
Why?
|
| Tuberous Sclerosis | 4 | 2011 | 1029 | 0.260 |
Why?
|
| Cell Line, Tumor | 21 | 2023 | 16674 | 0.260 |
Why?
|
| Central Nervous System | 3 | 2014 | 1358 | 0.250 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2004 | 44 | 0.250 |
Why?
|
| Societies, Medical | 5 | 2020 | 3740 | 0.250 |
Why?
|
| Cerebellum | 5 | 2022 | 1487 | 0.250 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 6363 | 0.240 |
Why?
|
| Male | 70 | 2022 | 349776 | 0.240 |
Why?
|
| Otx Transcription Factors | 2 | 2022 | 43 | 0.240 |
Why?
|
| Somatostatin | 4 | 2023 | 459 | 0.240 |
Why?
|
| Vestibular Diseases | 1 | 2006 | 217 | 0.240 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 2542 | 0.230 |
Why?
|
| North America | 3 | 2023 | 1249 | 0.230 |
Why?
|
| Lateral Ventricles | 1 | 2004 | 146 | 0.230 |
Why?
|
| Mitosis | 1 | 2009 | 1207 | 0.230 |
Why?
|
| DNA Methylation | 10 | 2019 | 4286 | 0.220 |
Why?
|
| Mice, SCID | 7 | 2020 | 2718 | 0.220 |
Why?
|
| Metencephalon | 1 | 2022 | 2 | 0.220 |
Why?
|
| ras Proteins | 3 | 2015 | 1059 | 0.220 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2020 | 169 | 0.220 |
Why?
|
| Mice | 37 | 2022 | 81154 | 0.210 |
Why?
|
| Neurogenesis | 3 | 2021 | 838 | 0.210 |
Why?
|
| Hypertension | 1 | 2022 | 8480 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 5 | 2012 | 9272 | 0.200 |
Why?
|
| Contraception, Immunologic | 3 | 1996 | 5 | 0.200 |
Why?
|
| Succinate Dehydrogenase | 1 | 2022 | 146 | 0.200 |
Why?
|
| Protein Kinases | 2 | 2008 | 1640 | 0.200 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2023 | 991 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 8 | 2020 | 6311 | 0.200 |
Why?
|
| Radiation Genetics | 1 | 2020 | 16 | 0.200 |
Why?
|
| Neurilemmoma | 1 | 2006 | 547 | 0.190 |
Why?
|
| Middle Aged | 44 | 2021 | 213241 | 0.190 |
Why?
|
| Neurons | 7 | 2019 | 9336 | 0.190 |
Why?
|
| Alpha Particles | 1 | 2020 | 26 | 0.190 |
Why?
|
| Prognosis | 13 | 2021 | 29052 | 0.190 |
Why?
|
| Receptors, Somatostatin | 2 | 2018 | 129 | 0.190 |
Why?
|
| DNA Copy Number Variations | 4 | 2018 | 1937 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2012 | 657 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5532 | 0.190 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2020 | 895 | 0.180 |
Why?
|
| Embryo, Mammalian | 3 | 2019 | 1702 | 0.180 |
Why?
|
| DNA Repair | 2 | 2020 | 2045 | 0.180 |
Why?
|
| Gene Expression Profiling | 13 | 2019 | 9440 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2017 | 4749 | 0.180 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 1203 | 0.180 |
Why?
|
| Anus Neoplasms | 1 | 2024 | 332 | 0.180 |
Why?
|
| Phenylurea Compounds | 2 | 2013 | 528 | 0.180 |
Why?
|
| DNA Damage | 2 | 2020 | 2429 | 0.180 |
Why?
|
| Cell Differentiation | 7 | 2022 | 11478 | 0.180 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 64 | 0.170 |
Why?
|
| Aged | 35 | 2021 | 163178 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2021 | 328 | 0.170 |
Why?
|
| Adult | 38 | 2021 | 213889 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2022 | 2649 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2021 | 473 | 0.160 |
Why?
|
| Animals | 40 | 2022 | 168660 | 0.160 |
Why?
|
| Receptors, Peptide | 1 | 2020 | 273 | 0.160 |
Why?
|
| Brain Stem Neoplasms | 2 | 2013 | 204 | 0.160 |
Why?
|
| Genomic Structural Variation | 2 | 2022 | 64 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2021 | 404 | 0.150 |
Why?
|
| Genomics | 6 | 2023 | 5714 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2020 | 5170 | 0.150 |
Why?
|
| Pteridines | 1 | 2017 | 45 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2011 | 2850 | 0.150 |
Why?
|
| Topotecan | 1 | 2017 | 137 | 0.150 |
Why?
|
| Dactinomycin | 1 | 2017 | 318 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2009 | 460 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1656 | 0.150 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 2017 | 31 | 0.150 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2217 | 0.150 |
Why?
|
| Neoplasm Metastasis | 6 | 2023 | 4848 | 0.150 |
Why?
|
| Neoplasm Staging | 12 | 2019 | 11036 | 0.150 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2018 | 200 | 0.150 |
Why?
|
| Arsenicals | 1 | 2017 | 124 | 0.150 |
Why?
|
| Aged, 80 and over | 17 | 2021 | 57744 | 0.150 |
Why?
|
| Prosencephalon | 1 | 2019 | 303 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1524 | 0.150 |
Why?
|
| Esophagogastric Junction | 1 | 2019 | 313 | 0.150 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 434 | 0.140 |
Why?
|
| Oncolytic Viruses | 1 | 2020 | 327 | 0.140 |
Why?
|
| Vitamins | 2 | 2019 | 1622 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 873 | 0.140 |
Why?
|
| Child, Preschool | 17 | 2021 | 40964 | 0.140 |
Why?
|
| Survival Rate | 8 | 2020 | 12786 | 0.140 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 748 | 0.140 |
Why?
|
| Genomic Instability | 1 | 2020 | 695 | 0.140 |
Why?
|
| Hospice Care | 1 | 2023 | 672 | 0.140 |
Why?
|
| Diarrhea | 2 | 2020 | 1348 | 0.140 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 112 | 0.140 |
Why?
|
| Apoptosis | 6 | 2020 | 9718 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2016 | 188 | 0.130 |
Why?
|
| Oxides | 1 | 2017 | 405 | 0.130 |
Why?
|
| Receptors, Cell Surface | 4 | 1996 | 2865 | 0.130 |
Why?
|
| Cyclin D1 | 1 | 2017 | 463 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4552 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2017 | 2217 | 0.130 |
Why?
|
| Microsatellite Instability | 2 | 2010 | 684 | 0.130 |
Why?
|
| Oligodendroglia | 1 | 2019 | 517 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2020 | 1188 | 0.130 |
Why?
|
| Oncolytic Virotherapy | 1 | 2020 | 498 | 0.130 |
Why?
|
| Treatment Outcome | 15 | 2020 | 63042 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 323 | 0.130 |
Why?
|
| Receptor, trkC | 1 | 2014 | 68 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2018 | 287 | 0.130 |
Why?
|
| Single-Cell Analysis | 2 | 2023 | 2177 | 0.130 |
Why?
|
| Vaccines, Synthetic | 3 | 1996 | 634 | 0.120 |
Why?
|
| Drug Administration Schedule | 2 | 2013 | 4931 | 0.120 |
Why?
|
| Proportional Hazards Models | 7 | 2020 | 12354 | 0.120 |
Why?
|
| Combined Modality Therapy | 4 | 2016 | 8637 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2017 | 5179 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.120 |
Why?
|
| Oncogenes | 3 | 2020 | 1265 | 0.120 |
Why?
|
| Cell Division | 2 | 2021 | 4568 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 539 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2013 | 2927 | 0.120 |
Why?
|
| Membrane Glycoproteins | 4 | 1996 | 3769 | 0.120 |
Why?
|
| Triazoles | 1 | 2020 | 904 | 0.120 |
Why?
|
| Cholecalciferol | 1 | 2019 | 536 | 0.120 |
Why?
|
| Receptor, trkB | 1 | 2014 | 125 | 0.120 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 705 | 0.120 |
Why?
|
| Maximum Tolerated Dose | 2 | 2013 | 892 | 0.120 |
Why?
|
| Dopamine | 1 | 2021 | 1592 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2012 | 771 | 0.110 |
Why?
|
| Glypicans | 1 | 2013 | 34 | 0.110 |
Why?
|
| Hypothalamic Neoplasms | 1 | 2013 | 22 | 0.110 |
Why?
|
| Child | 21 | 2022 | 77637 | 0.110 |
Why?
|
| Immunohistochemistry | 10 | 2017 | 11360 | 0.110 |
Why?
|
| DNA Helicases | 1 | 2019 | 861 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2017 | 550 | 0.110 |
Why?
|
| Gene Silencing | 2 | 2013 | 1537 | 0.110 |
Why?
|
| Survival Analysis | 6 | 2020 | 10251 | 0.110 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 1876 | 0.110 |
Why?
|
| Benzimidazoles | 1 | 2018 | 850 | 0.110 |
Why?
|
| Autoantibodies | 3 | 2005 | 2037 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2015 | 289 | 0.110 |
Why?
|
| Glutarates | 1 | 2014 | 236 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 424 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1520 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1799 | 0.110 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2014 | 320 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2021 | 5854 | 0.110 |
Why?
|
| Folic Acid | 2 | 2010 | 1293 | 0.110 |
Why?
|
| Infant | 12 | 2021 | 35122 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2018 | 1240 | 0.100 |
Why?
|
| Wnt Proteins | 2 | 2014 | 721 | 0.100 |
Why?
|
| Liver Neoplasms | 3 | 2017 | 4251 | 0.100 |
Why?
|
| Germ-Line Mutation | 2 | 2018 | 1787 | 0.100 |
Why?
|
| Retrospective Studies | 11 | 2024 | 77410 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
| Cohort Studies | 15 | 2021 | 40545 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2024 | 1587 | 0.100 |
Why?
|
| Genes, myc | 2 | 2012 | 399 | 0.100 |
Why?
|
| Hypothalamic Diseases | 1 | 2013 | 135 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 574 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2008 | 1097 | 0.100 |
Why?
|
| Young Adult | 13 | 2021 | 56392 | 0.100 |
Why?
|
| Fetus | 1 | 2019 | 1880 | 0.100 |
Why?
|
| Astrocytes | 1 | 2019 | 1273 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1861 | 0.100 |
Why?
|
| Vinblastine | 1 | 2013 | 501 | 0.100 |
Why?
|
| Bromodeoxyuridine | 2 | 2009 | 322 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2018 | 1533 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3082 | 0.100 |
Why?
|
| Epigenomics | 1 | 2016 | 903 | 0.100 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2010 | 25 | 0.100 |
Why?
|
| Stem Cells | 4 | 2015 | 3566 | 0.100 |
Why?
|
| Prospective Studies | 12 | 2024 | 53250 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1660 | 0.100 |
Why?
|
| Genes, ras | 1 | 2014 | 690 | 0.100 |
Why?
|
| Niacinamide | 1 | 2013 | 416 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2018 | 17439 | 0.090 |
Why?
|
| Adolescent | 17 | 2021 | 85729 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 59 | 0.090 |
Why?
|
| Mice, Nude | 5 | 2020 | 3680 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 505 | 0.090 |
Why?
|
| Lymph Node Excision | 1 | 2016 | 1262 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2010 | 27 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2914 | 0.090 |
Why?
|
| Patient Selection | 2 | 2020 | 4210 | 0.090 |
Why?
|
| Hydroxychloroquine | 1 | 2014 | 412 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2015 | 739 | 0.090 |
Why?
|
| Receptors, CXCR4 | 2 | 2006 | 727 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 1940 | 0.090 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2010 | 56 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 430 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2009 | 644 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2010 | 2037 | 0.090 |
Why?
|
| Medical Oncology | 2 | 2023 | 2267 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2022 | 646 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2019 | 4221 | 0.090 |
Why?
|
| Chromatin | 2 | 2023 | 2931 | 0.090 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2015 | 545 | 0.090 |
Why?
|
| Survival | 1 | 2010 | 163 | 0.090 |
Why?
|
| beta Catenin | 3 | 2010 | 1060 | 0.090 |
Why?
|
| Radiopharmaceuticals | 2 | 2009 | 2647 | 0.090 |
Why?
|
| Oophoritis | 2 | 1996 | 5 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2023 | 7908 | 0.080 |
Why?
|
| Cell Cycle | 3 | 2020 | 2963 | 0.080 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2009 | 94 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 623 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 1241 | 0.080 |
Why?
|
| Telomerase | 1 | 2013 | 731 | 0.080 |
Why?
|
| Cell Survival | 5 | 2019 | 5881 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 9648 | 0.080 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 693 | 0.080 |
Why?
|
| Somatomedins | 1 | 2008 | 192 | 0.080 |
Why?
|
| Neocortex | 1 | 2012 | 399 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2013 | 2938 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 7719 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 4033 | 0.080 |
Why?
|
| Quinolines | 1 | 2013 | 732 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 988 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 915 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 12066 | 0.080 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2009 | 178 | 0.080 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2008 | 200 | 0.080 |
Why?
|
| Lymphokines | 1 | 2001 | 948 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1222 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2018 | 3492 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2004 | 205 | 0.080 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 288 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 5692 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1396 | 0.070 |
Why?
|
| Disease Progression | 4 | 2024 | 13273 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2001 | 798 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14563 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2017 | 8436 | 0.070 |
Why?
|
| Vitamin B 12 | 1 | 2010 | 527 | 0.070 |
Why?
|
| Insulin | 2 | 2013 | 6584 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2016 | 2945 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2017 | 9731 | 0.070 |
Why?
|
| Zona Pellucida | 1 | 1996 | 18 | 0.070 |
Why?
|
| Forecasting | 1 | 2015 | 2950 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3292 | 0.070 |
Why?
|
| Point Mutation | 1 | 2011 | 1623 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3476 | 0.070 |
Why?
|
| Autophagy | 1 | 2014 | 1296 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3463 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1677 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2009 | 2725 | 0.070 |
Why?
|
| Histones | 2 | 2023 | 2598 | 0.070 |
Why?
|
| Ear Canal | 1 | 2006 | 146 | 0.070 |
Why?
|
| Translocation, Genetic | 3 | 2022 | 1420 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2119 | 0.070 |
Why?
|
| CpG Islands | 1 | 2010 | 1170 | 0.070 |
Why?
|
| Recurrence | 3 | 2019 | 8337 | 0.070 |
Why?
|
| Research Design | 1 | 2021 | 5983 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2015 | 1938 | 0.070 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 113 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2013 | 5078 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2010 | 981 | 0.060 |
Why?
|
| Leucovorin | 2 | 2019 | 628 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2018 | 3439 | 0.060 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 1372 | 0.060 |
Why?
|
| Ribosomal Protein S6 | 1 | 2004 | 70 | 0.060 |
Why?
|
| DNA Mismatch Repair | 1 | 2008 | 426 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2008 | 671 | 0.060 |
Why?
|
| Tumor Burden | 3 | 2017 | 1917 | 0.060 |
Why?
|
| Rhabdomyoma | 1 | 2004 | 57 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2281 | 0.060 |
Why?
|
| Body Patterning | 1 | 2009 | 629 | 0.060 |
Why?
|
| Ovarian Diseases | 1 | 1996 | 139 | 0.060 |
Why?
|
| Risk Factors | 12 | 2021 | 72252 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2015 | 1970 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2021 | 1862 | 0.060 |
Why?
|
| Ovary | 2 | 1996 | 980 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2014 | 3480 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2014 | 2614 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2004 | 197 | 0.060 |
Why?
|
| Anilides | 2 | 2018 | 409 | 0.060 |
Why?
|
| Autoimmune Diseases | 2 | 1996 | 2134 | 0.060 |
Why?
|
| Alleles | 4 | 2013 | 6934 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 1351 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 975 | 0.060 |
Why?
|
| Organoplatinum Compounds | 2 | 2019 | 408 | 0.060 |
Why?
|
| Physical Exertion | 1 | 2006 | 695 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2017 | 2758 | 0.060 |
Why?
|
| Data Collection | 1 | 2013 | 3339 | 0.060 |
Why?
|
| Neoplasms | 3 | 2021 | 21675 | 0.060 |
Why?
|
| Indoles | 2 | 2009 | 1841 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2022 | 12209 | 0.060 |
Why?
|
| Estradiol | 1 | 2010 | 2017 | 0.060 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2022 | 25 | 0.060 |
Why?
|
| Quality of Life | 2 | 2023 | 12788 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2014 | 1952 | 0.050 |
Why?
|
| DNA Mutational Analysis | 3 | 2018 | 4183 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3283 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2010 | 1950 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1147 | 0.050 |
Why?
|
| Anxiety | 1 | 2017 | 4288 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2004 | 684 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2023 | 288 | 0.050 |
Why?
|
| Fluorouracil | 2 | 2019 | 1619 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2005 | 572 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4204 | 0.050 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2002 | 31 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 1142 | 0.050 |
Why?
|
| Aging | 1 | 2021 | 8655 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12954 | 0.050 |
Why?
|
| United States | 6 | 2023 | 69859 | 0.050 |
Why?
|
| Heparin | 1 | 2009 | 1637 | 0.050 |
Why?
|
| Electroporation | 2 | 2014 | 251 | 0.050 |
Why?
|
| SEER Program | 2 | 2017 | 1507 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2011 | 2039 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2004 | 374 | 0.050 |
Why?
|
| Radiography | 1 | 2012 | 7010 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21824 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2575 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 15518 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 7793 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 2016 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2013 | 496 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3917 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 644 | 0.050 |
Why?
|
| Multigene Family | 2 | 2014 | 1101 | 0.050 |
Why?
|
| Camptothecin | 2 | 2014 | 576 | 0.050 |
Why?
|
| Formaldehyde | 2 | 2012 | 353 | 0.050 |
Why?
|
| Cell Movement | 2 | 2018 | 5216 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 906 | 0.040 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2924 | 0.040 |
Why?
|
| Protein Binding | 2 | 2009 | 9377 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2022 | 471 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2022 | 321 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18027 | 0.040 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2019 | 102 | 0.040 |
Why?
|
| Dyspepsia | 1 | 2020 | 115 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 4152 | 0.040 |
Why?
|
| Autoantigens | 1 | 1994 | 892 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 3504 | 0.040 |
Why?
|
| Infertility, Female | 1 | 1995 | 788 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 1083 | 0.040 |
Why?
|
| Genome, Human | 1 | 2012 | 4418 | 0.040 |
Why?
|
| Paraffin Embedding | 2 | 2011 | 299 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2009 | 2159 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2017 | 2712 | 0.040 |
Why?
|
| Infertility | 1 | 1996 | 655 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 15067 | 0.040 |
Why?
|
| Gastritis | 1 | 2020 | 196 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2018 | 58 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 209 | 0.040 |
Why?
|
| Consent Forms | 1 | 2018 | 53 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13028 | 0.040 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1608 | 0.040 |
Why?
|
| Annexin A5 | 1 | 2018 | 103 | 0.040 |
Why?
|
| Parabiosis | 1 | 2018 | 65 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2023 | 602 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2019 | 275 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2019 | 437 | 0.040 |
Why?
|
| Postmenopause | 1 | 2006 | 2458 | 0.040 |
Why?
|
| Heredity | 1 | 2018 | 154 | 0.040 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2017 | 65 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 172 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2020 | 336 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2916 | 0.040 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2017 | 90 | 0.040 |
Why?
|
| Depression | 1 | 2017 | 7760 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2012 | 893 | 0.040 |
Why?
|
| Flushing | 1 | 2017 | 48 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 5892 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3645 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 11059 | 0.040 |
Why?
|
| Macrophages | 2 | 2023 | 5651 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 1158 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 375 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7880 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2020 | 2969 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.030 |
Why?
|
| T-Lymphocytes | 4 | 2020 | 10179 | 0.030 |
Why?
|
| Motor Activity | 1 | 2006 | 2714 | 0.030 |
Why?
|
| Amino Acid Sequence | 5 | 2005 | 13809 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2002 | 570 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 9944 | 0.030 |
Why?
|
| Age Factors | 3 | 2018 | 18355 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2183 | 0.030 |
Why?
|
| H-2 Antigens | 2 | 1996 | 366 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 620 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2018 | 765 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2011 | 2942 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 2203 | 0.030 |
Why?
|
| Vaccines | 1 | 1994 | 823 | 0.030 |
Why?
|
| Deoxycytidine | 2 | 2009 | 826 | 0.030 |
Why?
|
| Alberta | 1 | 2014 | 64 | 0.030 |
Why?
|
| Pyridines | 2 | 2018 | 2827 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2019 | 12020 | 0.030 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2020 | 445 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 18107 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2019 | 907 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2014 | 19232 | 0.030 |
Why?
|
| Proteins | 2 | 2012 | 6098 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2015 | 105 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12243 | 0.030 |
Why?
|
| Lasers | 1 | 2019 | 949 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2014 | 9848 | 0.030 |
Why?
|
| Benzylamines | 2 | 2006 | 223 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3130 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1117 | 0.030 |
Why?
|
| Heterocyclic Compounds | 2 | 2006 | 248 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2013 | 76 | 0.030 |
Why?
|
| Pancreas | 1 | 2021 | 1686 | 0.030 |
Why?
|
| Thromboplastin | 1 | 2015 | 291 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 690 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6237 | 0.030 |
Why?
|
| Cytogenetics | 1 | 2014 | 203 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2022 | 2506 | 0.030 |
Why?
|
| Indazoles | 1 | 2015 | 290 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 1691 | 0.030 |
Why?
|
| Chromogranin A | 1 | 2013 | 54 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 299 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2010 | 2085 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2012 | 2006 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1875 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 1996 | 1826 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2013 | 173 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2017 | 895 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 417 | 0.030 |
Why?
|
| Paraffin | 1 | 2012 | 35 | 0.030 |
Why?
|
| Vertebrates | 1 | 2014 | 228 | 0.030 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2012 | 96 | 0.030 |
Why?
|
| Disease Management | 1 | 2023 | 2459 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3591 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1707 | 0.030 |
Why?
|
| Microglia | 1 | 2020 | 1267 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 553 | 0.030 |
Why?
|
| Sex Factors | 2 | 2016 | 10394 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 670 | 0.030 |
Why?
|
| Myocardium | 1 | 2004 | 4775 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 733 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2131 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2013 | 1102 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 1444 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1161 | 0.020 |
Why?
|
| Hydroxyestrones | 1 | 2010 | 17 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2014 | 519 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2009 | 1758 | 0.020 |
Why?
|
| Half-Life | 1 | 2012 | 660 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2077 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2012 | 328 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 933 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2009 | 0.020 |
Why?
|
| Gene Fusion | 1 | 2013 | 371 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6170 | 0.020 |
Why?
|
| Canada | 1 | 2016 | 2064 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 894 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2503 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 12944 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2010 | 40 | 0.020 |
Why?
|
| Pedigree | 1 | 2018 | 4643 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2001 | 251 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 3000 | 0.020 |
Why?
|
| Exercise | 1 | 2006 | 5611 | 0.020 |
Why?
|
| DNA | 1 | 2024 | 7295 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2014 | 420 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 20827 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 2750 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 534 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 140 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2009 | 154 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2013 | 1728 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2008 | 52 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2008 | 135 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1729 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39001 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2008 | 16 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2008 | 123 | 0.020 |
Why?
|
| Palliative Care | 1 | 2023 | 3490 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2010 | 420 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 1545 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2001 | 689 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 2646 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19894 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
| Cell Line | 1 | 2022 | 15993 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2008 | 241 | 0.020 |
Why?
|
| Risk | 2 | 2010 | 9677 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 612 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3268 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3794 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6620 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2504 | 0.020 |
Why?
|
| C-Peptide | 1 | 2008 | 420 | 0.020 |
Why?
|
| Phenotype | 2 | 2018 | 16361 | 0.020 |
Why?
|
| Carmustine | 1 | 2006 | 137 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 424 | 0.020 |
Why?
|
| Protons | 1 | 2012 | 1129 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10940 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 4320 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 769 | 0.020 |
Why?
|
| Laminin | 1 | 2008 | 419 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2005 | 25 | 0.020 |
Why?
|
| Time Factors | 3 | 2019 | 40038 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2014 | 23327 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2014 | 2615 | 0.020 |
Why?
|
| Litter Size | 1 | 1995 | 54 | 0.020 |
Why?
|
| Fluoroimmunoassay | 1 | 2005 | 33 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3847 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1524 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 1995 | 248 | 0.020 |
Why?
|
| Quinazolines | 1 | 2012 | 1356 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6535 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7324 | 0.020 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2005 | 32 | 0.020 |
Why?
|
| Vitamin D | 1 | 2019 | 3222 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3608 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1452 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 349 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 1996 | 311 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 916 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2004 | 121 | 0.020 |
Why?
|
| Solutions | 1 | 2005 | 426 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2891 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2005 | 215 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2015 | 25609 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 2005 | 308 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 1683 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6356 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2004 | 117 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 1709 | 0.020 |
Why?
|
| Glycogen | 1 | 2004 | 259 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2692 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 749 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1986 | 0.010 |
Why?
|
| Piperidines | 1 | 2012 | 1601 | 0.010 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 12259 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2008 | 1252 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2012 | 2500 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 1619 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 1994 | 201 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13980 | 0.010 |
Why?
|
| Retina | 1 | 2014 | 2612 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 1344 | 0.010 |
Why?
|
| Plasmids | 1 | 2008 | 2308 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2008 | 1958 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1794 | 0.010 |
Why?
|
| Prostate | 1 | 2010 | 1763 | 0.010 |
Why?
|
| Integrases | 1 | 2004 | 533 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 480 | 0.010 |
Why?
|
| Sural Nerve | 1 | 2002 | 106 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2132 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2003 | 422 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 489 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3503 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4803 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 604 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 733 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21733 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 2480 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2003 | 465 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1855 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2419 | 0.010 |
Why?
|
| Pregnancy | 2 | 2014 | 29140 | 0.010 |
Why?
|
| Brain | 2 | 2023 | 26345 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2008 | 3912 | 0.010 |
Why?
|
| Immunization | 1 | 1995 | 1255 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 4737 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10629 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 2017 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2002 | 441 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2003 | 607 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 1613 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2009 | 1879 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2086 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2890 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 2944 | 0.010 |
Why?
|
| Collagen | 1 | 2008 | 2681 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2839 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2012 | 5021 | 0.010 |
Why?
|
| Decision Making | 1 | 2013 | 3887 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3690 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 7729 | 0.010 |
Why?
|
| Autoimmunity | 1 | 1995 | 1349 | 0.010 |
Why?
|
| Epitopes | 1 | 1994 | 2570 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3772 | 0.010 |
Why?
|
| Nurses | 1 | 2006 | 2461 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3617 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5752 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9582 | 0.010 |
Why?
|
| Life Style | 1 | 2006 | 3833 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35409 | 0.010 |
Why?
|
| Liver | 1 | 2008 | 7479 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1994 | 5524 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2004 | 3817 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 12798 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2005 | 3079 | 0.010 |
Why?
|
| Biopsy | 1 | 2002 | 6750 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20121 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 4255 | 0.000 |
Why?
|